The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy
Abstract Nuclear medicine has evolved over the last half-century from a functional imaging modality using a handful of radiopharmaceuticals, many of unknown structure and mechanism of action, into a modern speciality that can properly be described as molecular imaging, with a very large number of sp...
Main Authors: | Timothy H. Witney, Philip J. Blower |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Cancer Imaging |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40644-021-00385-8 |
Similar Items
-
Editorial: Positron Emission Tomography (PET) Imaging of Brain Biochemistry: Beyond High-Affinity Radioligands
by: Michael R. Kilbourn, et al.
Published: (2022-05-01) -
Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
by: Anh Thu Nguyen, et al.
Published: (2023-06-01) -
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
by: George Crișan, et al.
Published: (2022-04-01) -
Design, Synthesis and Molecular Modeling Study of Radiotracers Based on Tacrine and Its Derivatives for Study on Alzheimer’s Disease and Its Early Diagnosis
by: Przemysław Koźmiński, et al.
Published: (2024-03-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
by: P. August Schubiger, et al.
Published: (2004-10-01)